Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Febuxostat pharmacokinetics and urate response in chronic gout
ACTRN12616000959471Phase 4Recruiting
- Sponsor
- St Vincent's Hospital
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of febuxostat in gout, sponsored by St Vincent's Hospital. Primary endpoint: Change in serum urate concentration. Started Sep 2016; status: recruiting.
02
Drugs
febuxostat
03
Conditions
gout
Beyond the preview
Go deeper on ACTRN12616000959471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000959471.